CD4 and melanoma: Using melanoma-derived cell lines and primary CD4+ CD25- T cell co-cultures, Rad Pour and colleagues demonstrated that activation of CD4+ T cells results in increased production of IFNγ with concomitant increases in Kyn and kynurenic acid that is attributed to reduced KMO expression in CD4+ T cells (25).